These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biventricular defibrillator patients have higher complication rates after revision of recalled leads. Brumberg GE; Kaseer B; Shah H; Saba S; Jain S Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559 [TBL] [Abstract][Full Text] [Related]
4. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026 [TBL] [Abstract][Full Text] [Related]
5. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Haghjoo M; Nikoo MH; Fazelifar AF; Alizadeh A; Emkanjoo Z; Sadr-Ameli MA Europace; 2007 May; 9(5):328-32. PubMed ID: 17369270 [TBL] [Abstract][Full Text] [Related]
6. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L; Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665 [TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of lead revision for myocardial perforation after cardiac implantable electronic device placement. Huang XM; Fu HX; Zhong L; Osborn MJ; Asirvatham SJ; Sinak LJ; Cao J; Friedman PA; Cha YM J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1119-24. PubMed ID: 24863054 [TBL] [Abstract][Full Text] [Related]
9. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients. Adelstein E; Saba S Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497 [TBL] [Abstract][Full Text] [Related]
11. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Downey BC; Juselius WE; Pandian NG; Estes NA; Link MS Pacing Clin Electrophysiol; 2011 Jun; 34(6):679-83. PubMed ID: 21303389 [TBL] [Abstract][Full Text] [Related]
12. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431 [TBL] [Abstract][Full Text] [Related]
13. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Greenspon AJ; Rhim ES; Mark G; Desimone J; Ho RT Pacing Clin Electrophysiol; 2008 May; 31(5):548-53. PubMed ID: 18439167 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study. Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316 [TBL] [Abstract][Full Text] [Related]
16. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Golzio PG; Fanelli AL; Vinci M; Pelissero E; Morello M; Grosso Marra W; Gaita F Europace; 2013 Jan; 15(1):89-100. PubMed ID: 22968846 [TBL] [Abstract][Full Text] [Related]